Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -1.42%278 | -1.42%278 | -19.86%226 | -20.11%1.13K | -20.11%282 | -20.11%282 | -20.11%282 | -20.11%282 | ||
| Gross profit | 1.42%-278 | 1.42%-278 | 19.86%-226 | 20.11%-1.13K | 20.11%-282 | 20.11%-282 | 20.11%-282 | 20.11%-282 | ||
| Operating expense | 31.81%1.03M | -40.80%193.28K | 195.22%485.69K | 15.16%191.77K | 28.46%155.93K | -8.44%778.89K | 193.78%326.47K | -42.11%164.52K | -22.07%166.53K | -49.78%121.38K |
| Selling and administrative expenses | 35.80%944.93K | -44.48%172.19K | 236.36%468.59K | 18.59%167.11K | 28.62%137.03K | -6.62%695.8K | 209.15%310.13K | -38.07%139.32K | -24.65%140.91K | -48.99%106.55K |
| -Selling and marketing expense | -15.08%32.31K | -84.80%1.73K | -76.33%4.13K | 173.48%19.54K | 232.80%6.91K | -64.64%38.05K | 115.87%11.38K | -8.48%17.44K | -17.65%7.15K | -97.22%2.08K |
| -General and administrative expense | 38.75%912.62K | -42.94%170.46K | 281.10%464.47K | 10.32%147.57K | 24.56%130.13K | 3.17%657.75K | 214.33%298.74K | -40.81%121.87K | -24.99%133.77K | -22.21%104.47K |
| Depreciation amortization depletion | -6.03%1.06K | -1.42%278 | -1.42%278 | -1.42%278 | -19.86%226 | -20.11%1.13K | -20.11%282 | -20.11%282 | -20.11%282 | -20.11%282 |
| -Depreciation and amortization | -6.03%1.06K | -1.42%278 | -1.42%278 | -1.42%278 | -19.86%226 | -20.11%1.13K | -20.11%282 | -20.11%282 | -20.11%282 | -20.11%282 |
| Other operating expenses | -1.56%80.69K | 29.62%20.81K | -32.50%16.82K | -3.74%24.38K | 28.28%18.67K | -21.27%81.96K | 53.58%16.06K | -57.67%24.92K | -3.71%25.33K | -55.18%14.55K |
| Operating profit | -31.81%-1.03M | 40.80%-193.28K | -195.22%-485.69K | -15.16%-191.77K | -28.46%-155.93K | 8.44%-778.89K | -193.78%-326.47K | 42.11%-164.52K | 22.07%-166.53K | 49.78%-121.38K |
| Net non-operating interest income (expenses) | -101.06%-1.34K | -105.88%-1.56K | -104.86%-1.34K | -89.57%3.53K | -105.20%-1.98K | 91.79%125.94K | -24.62%26.52K | -33.62%27.5K | -23.69%33.9K | 168.69%38.03K |
| Non-operating interest income | -95.92%5.38K | -99.62%112 | -99.91%27 | -85.36%5.1K | -99.65%135 | 91.62%131.83K | -20.01%29.12K | -31.14%29.04K | -22.49%34.86K | --38.82K |
| Non-operating interest expense | ---- | ---- | -11.89%1.36K | 63.78%1.57K | 167.59%2.11K | 87.95%5.9K | 111.98%2.6K | 104.90%1.55K | 74.50%958 | -98.56%790 |
| Total other finance cost | 13.91%6.72K | -35.79%1.67K | -11.89%1.36K | 63.78%1.57K | 167.59%2.11K | 87.95%5.9K | 111.98%2.6K | 104.90%1.55K | 74.50%958 | 30.36%790 |
| Other net income (expenses) | 99.42%-1.04K | -125.83%-436 | -66.04%-616 | -188.57%-101 | 100.07%118 | 83.13%-177.67K | 100.11%1.69K | -100.07%-371 | -108.75%-35 | -55,646.73%-178.95K |
| Gain on sale of security | 99.42%-1.04K | -125.83%-436 | -66.04%-616 | -188.57%-101 | 100.07%118 | -444.71%-177.67K | 100.38%1.69K | -100.07%-371 | -108.75%-35 | -55,646.73%-178.95K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | -23.89%-1.03M | 34.53%-195.28K | -254.92%-487.65K | -41.97%-188.33K | 39.84%-157.79K | 54.81%-830.62K | 81.65%-298.26K | -154.25%-137.4K | 21.44%-132.66K | 11.79%-262.3K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -23.89%-1.03M | 34.53%-195.28K | -254.92%-487.65K | -41.97%-188.33K | 39.84%-157.79K | 54.81%-830.62K | 81.65%-298.26K | -154.25%-137.4K | 21.44%-132.66K | 11.79%-262.3K |
| Net income continuous operations | -23.89%-1.03M | 34.53%-195.28K | -254.92%-487.65K | -41.97%-188.33K | 39.84%-157.79K | 54.81%-830.62K | 81.65%-298.26K | -154.25%-137.4K | 21.44%-132.66K | 11.79%-262.3K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -23.89%-1.03M | 34.53%-195.28K | -254.92%-487.65K | -41.97%-188.33K | 39.84%-157.79K | 54.81%-830.62K | 81.65%-298.26K | -154.25%-137.4K | 21.44%-132.66K | 11.79%-262.3K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -23.89%-1.03M | 34.53%-195.28K | -254.92%-487.65K | -41.97%-188.33K | 39.84%-157.79K | 54.81%-830.62K | 81.65%-298.26K | -154.25%-137.4K | 21.44%-132.66K | 11.79%-262.3K |
| Diluted earnings per share | 0.00%-0.02 | 0 | -0.01 | 0 | 0 | 50.00%-0.02 | 66.67%-0.01 | 0 | 0 | 0.00%-0.01 |
| Basic earnings per share | 0.00%-0.02 | 0 | -0.01 | 0 | 0 | 50.00%-0.02 | 66.67%-0.01 | 0 | 0 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.